Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[nep2134]

It's 3 year old data. They should now have completed Nilvadipine trial data. Mullan is now saying amyloid is a bust.

There is some much more to anatabine then Alzheimer's. Much more. I want to complete at least one mice study this year. Trying to figure out who to write the check to. And which study I want to do first. I have multiple studies I want to do. Some are fairly quick, month or two at most.

Might even see about getting Roskamp to do one of them for me. They should already be setup to do them and are familiar with anatabine. Need to do a lot of vetting and get some answers before I would go with them. And sign lots of legal stuff protecting any patent rights.